-
3781por Bhattacharya, Udayan, Thavathiru, Elangovan, Neizer-Ashun, Fiifi, Xu, Chao, Gatalica, Zoran, Dwivedi, Shailendra Kumar Dhar, Dey, Anindya, Mukherjee, Priyabrata, Bhattacharya, Resham“…Our studies suggest that USP10 by protecting pancreatic cancer cells from ER stress may support tumor progression.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3782por Herremans, Kelly M., Riner, Andrea N., Charles, Angel M., Balch, Jeremy A., Vudatha, Vignesh, Freudenberger, Devon C., Nassour, Ibrahim, Hughes, Steven J., Trevino, Jose G., Loftus, Tyler J.Enlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3783por Debernardi, Silvana, Blyuss, Oleg, Rycyk, Daria, Srivastava, Kirtiman, Jeon, Christie Y., Cai, Hui, Cai, Qiuyin, Shu, Xiao‐Ou, Crnogorac‐Jurcevic, TatjanaEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3784por Dong, Shi, Li, Wancheng, Li, Xin, Wang, Zhengfeng, Chen, Zhou, Shi, Huaqing, He, Ru, Chen, Chen, Zhou, Wence“…Early and accurate diagnosis and treatment of pancreatic cancer (PC) remain challenging endeavors globally. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3785por Hara, Kazushi, Horikoshi, Yosuke, Morimoto, Masaki, Nakaso, Kazuhiro, Sunaguchi, Teppei, Kurashiki, Tatsuyuki, Nakayama, Yuji, Hanaki, Takehiko, Yamamoto, Manabu, Sakamoto, Teruhisa, Fujiwara, Yoshiyuki, Matsura, Tatsuya“…Pancreatic cancer (PC) is an aggressive malignancy with few treatment options, and improved treatment strategies are urgently required. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3786por Lidström, Tommy, Cumming, Joshua, Gaur, Rahul, Frängsmyr, Lars, Pateras, Ioannis S., Mickert, Matthias J., Franklin, Oskar, Forsell, Mattias N.E., Arnberg, Niklas, Dongre, Mitesh, Patthey, Cedric, Öhlund, DanielEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3787por Kim, Hyo Suk, Gweon, Tae-Geun, Park, Sang Hi, Kim, Tae Ho, Kim, Chang Whan, Chang, Jae Hyuck“…We aimed to present the incidence and risk factors for pancreatic cancer in a multicenter retrospective cohort of patients with chronic pancreatitis (CP). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3788por Jung, Jae Hyup, Song, Changhoon, Jung, In Ho, Ahn, Jinwoo, Kim, Bomi, Jung, Kwangrok, Lee, Jong-Chan, Kim, Jaihwan, Hwang, Jin-Hyeok“…INTRODUCTION: FOLFIRINOX (the combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin) is the preferred systemic regimen for locally advanced pancreatic cancer (LAPC). Furthermore, stereotactic body radiation therapy (SBRT) is a promising treatment option for achieving local control in these patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3789por Jeon, Hyun Jeong, Jeong, Hye Jeong, Lim, Soo Yeun, Yoon, So Jeong, Kim, Hongbeom, Han, In Woong, Heo, Jin Seok, Shin, Sang Hyun“…SIMPLE SUMMARY: In pancreatic cancer, complete pathologic response (cPR) after neoadjuvant treatment (NAT) has been rarely reported and its clinical course is not well known. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3790por Botrus, Gehan, Miller, Richard M., Uson Junior, Pedro Luiz Serrano, Kannan, Geoffrey, Han, Haiyong, Von Hoff, Daniel D.“…High rates of cell proliferation and protein synthesis in pancreatic cancer are among many factors leading to endoplasmic reticulum (ER) stress. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3791por Nicoletti, Alberto, Negri, Marcantonio, Paratore, Mattia, Vitale, Federica, Ainora, Maria Elena, Nista, Enrico Celestino, Gasbarrini, Antonio, Zocco, Maria Assunta, Zileri Dal Verme, Lorenzo“…Pancreatic cancer is one of the most aggressive tumors, with a dismal prognosis due to poor detection rates at early stages, rapid progression, post-surgical complications, and limited effectiveness of conventional oncologic therapies. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3792por Ikezawa, Kenji, Tanaka, Sachiko, Fukuda, Junko, Nakao, Miho, Nakano, Yoko, Chagi, Mayumi, Yamanaka, Hiromi, Ohkawa, Kazuyoshi“…Although main pancreatic duct dilatation and pancreatic cysts are risk factors for developing pancreatic cancer, limited data exist regarding these findings in relatives and spouses of pancreatic cancer patients. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3793por Kasuga, Akiyoshi, Nojima, Masanori, Okamoto, Takeshi, Ishitsuka, Takahiro, Yamada, Manabu, Nakagawa, Hiroki, Udagawa, Shohei, Mori, Chinatsu, Mie, Takafumi, Furukawa, Takaaki, Yamada, Yuto, Takeda, Tsuyoshi, Matsuyama, Masato, Sasaki, Takashi, Ozaka, Masato, Sasahira, Naoki“…The present study evaluated the impact of COVID-19 on the outcomes of unresectable pancreatic cancer (PC) patients who received end-of-life care. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3794por Papalazarou, Vasileios, Drew, James, Juin, Amelie, Spence, Heather J., Whitelaw, Jamie, Nixon, Colin, Salmeron-Sanchez, Manuel, Machesky, Laura M.“…Pancreatic cancer is a deadly and highly metastatic disease, although how metastatic lesions establish is not fully understood. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3795Vibrational spectroscopy – are we close to finding a solution for early pancreatic cancer diagnosis?“…Pancreatic cancer (PC) is an aggressive and lethal neoplasm, ranking seventh in the world for cancer deaths, with an overall 5-year survival rate of below 10%. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3796por Shaya, Justin, Kato, Shumei, Adashek, Jacob J., Patel, Hitendra, Fanta, Paul T., Botta, Gregory P., Sicklick, Jason K., Kurzrock, Razelle“…Despite progress, 2-year pancreatic cancer survival remains dismal. We evaluated a biomarker-driven, combination/N-of-one strategy in 18 patients (advanced/metastatic pancreatic cancer) (from Molecular Tumor Board). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3797por Davis, Evan W., McCann, Susan E., Joseph, Janine M., Yeary, Karen H. K., Fountzilas, Christos, Moysich, Kirsten B.“…Pancreatic cancer (PanCa) is a highly fatal malignancy with few modifiable risk and prognostic factors. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3798por Tsiotos, Gregory G., Ballian, Nikiforos, Milas, Fotios, Ziogou, Panoraia, Papaioannou, Dimitrios, Salla, Charitini, Athanasiadis, Ilias, Stavridi, Flora, Strimpakos, Alexios, Psomas, Maria, Kostopanagiotou, Georgia“…BACKGROUND: Patients with pancreatic cancer (PC), which may involve major peripancreatic vessels, have been generally excluded from surgery, as resection was deemed futile. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3799por De Santis, Maria Chiara, Gozzelino, Luca, Margaria, Jean Piero, Costamagna, Andrea, Ratto, Edoardo, Gulluni, Federico, Di Gregorio, Enza, Mina, Erica, Lorito, Nicla, Bacci, Marina, Lattanzio, Rossano, Sala, Gianluca, Cappello, Paola, Novelli, Francesco, Giovannetti, Elisa, Vicentini, Caterina, Andreani, Silvia, Delfino, Pietro, Corbo, Vincenzo, Scarpa, Aldo, Porporato, Paolo Ettore, Morandi, Andrea, Hirsch, Emilio, Martini, MiriamEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3800“…BACKGROUND: Pancreatic cancer (PAAD) is a malignant tumor with a poor prognosis and lacks sensitive biomarkers for diagnosis and targeted therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto